What Does Wegovy Cost in 2026?
Wegovy is the most prescribed GLP-1 weight loss medication in the United States — and 2026 has brought the most dramatic pricing changes since it launched. Between the new oral tablet, self-pay intro programs, and upcoming Medicare coverage, the price you pay depends entirely on how you access it.
Here's every current Wegovy price, broken down by access path, so you can find the one that fits your budget.
The Headline
Wegovy now ranges from $25 to $1,349/mo depending on your path. Most people should not be paying list price in 2026.
Wegovy Pill vs. Injection: Price Comparison
The biggest news in GLP-1 pricing this year is the Wegovy pill, approved by the FDA in late 2025 and launched in January 2026. For the first time, patients can take semaglutide as a daily oral tablet instead of a weekly injection.
| Option | Intro Price | Ongoing Price | Notes |
|---|---|---|---|
| Wegovy Pill (1.5mg/4mg) | $149/mo | $349/mo | Self-pay via NovoCare. 4mg intro through Apr 15. |
| Wegovy Injection (0.25/0.5mg) | $199/mo | $349/mo | New patients, first 2 fills. Through Jun 30, 2026. |
| Wegovy w/ Insurance + Savings Card | As low as $25/mo | $25–$200/mo | Commercially insured. Max savings $100/mo. |
| Wegovy HD (7.2mg injection) | TBD | TBD | FDA approved Mar 2026. Available ~Apr 2026. |
| Wegovy List Price (no programs) | $1,349/mo | What you'd pay at a retail pharmacy with no help. | |
The pill's $149/mo intro is currently the cheapest way to start FDA-approved semaglutide for weight loss — period. That's less than most compounded options.
Insurance Coverage in 2026
Insurance coverage for Wegovy remains inconsistent. Most commercial plans require prior authorization, and many still exclude weight loss medications entirely.
If your insurance does cover Wegovy, stacking the Wegovy Savings Card brings your copay as low as $25/month — the absolute cheapest path. The savings card provides up to $100/month in copay assistance for up to 48 months.
If your insurance denies coverage, you still have strong options. The NovoCare self-pay programs eliminate the need for insurance entirely, and compounded alternatives offer even lower prices for those comfortable with non-FDA-approved options.
Medicare Coverage: The $50/Month Program
Starting July 1, 2026, Medicare Part D plans will begin covering GLP-1 medications for weight loss through a temporary bridge program. Copays will be capped at $50/month through December 31, 2026. This is a historic shift — Medicare has never covered anti-obesity medications before.
If you're on Medicare and waiting, this is worth holding out for. $50/month for brand-name Wegovy is less than half the cost of most compounded alternatives.
Compounded Semaglutide: How It Compares
Compounded semaglutide is not FDA-approved Wegovy — it's a custom-made version of the same active ingredient, prepared by licensed compounding pharmacies. Prices range from about $146 to $299/month depending on the provider.
The regulatory landscape shifted significantly in early 2026. The FDA ended the semaglutide shortage in February 2025 and tightened compounding rules, meaning compounded versions are now only available for patients who meet specific eligibility criteria (such as allergies or non-standard dosing needs).
For patients who do qualify, compounded semaglutide remains the most affordable cash-pay option:
Yucca Health — From $146/mo
One of the lowest intro prices for compounded semaglutide. Tirzepatide available from $258/mo. Buy-now-pay-later options available.
Check Availability →Sponsored · Compounded medications are not FDA-approved.
Synergy Rx — From $200/mo
All-inclusive compounded semaglutide. No hidden fees — consultation, medication, and shipping bundled into one price.
Check Availability →Sponsored · Compounded medications are not FDA-approved.
Wegovy HD: The New High Dose
In March 2026, the FDA approved Wegovy HD — a 7.2mg injectable dose that's three times the standard 2.4mg maintenance dose. It's designed for patients who've plateaued on 2.4mg and need additional weight loss. Clinical trials showed significantly greater weight reduction compared to the standard dose.
Wegovy HD is expected to be available in pharmacies by April 2026. Pricing hasn't been finalized, but it will likely be covered under the same manufacturer savings programs as existing Wegovy doses.
What Should You Do?
Your best path depends on your specific situation:
Best overall value in 2026: If you have commercial insurance with Wegovy coverage, the savings card at $25/month is unbeatable.
Best for uninsured/self-pay: Start with the Wegovy pill at $149/month — it's cheaper than most compounded options and it's FDA-approved.
Best for Medicare patients: Wait for the $50/month bridge program in July 2026 if you can.
Best for budget-conscious cash-pay: Compounded semaglutide from $146/month if you meet eligibility requirements.
Sesame Care — FDA-Approved Medications
Real video visits with licensed providers. Access brand-name Wegovy, Ozempic, and Zepbound with manufacturer savings programs.
See Options →Sponsored
The Bottom Line
Wegovy pricing in 2026 is the most competitive it's ever been. Between the $149 pill, $199 injection intro, insurance savings cards, and the upcoming Medicare bridge, most patients have a realistic path to affordable treatment. The days of "$1,300/month or nothing" are over.
Use our True Monthly Cost Calculator to see exactly what you'd pay over 12 months with dose titration factored in.